| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |